Ceribell inc CBLL.US 總覽分析

美股醫療保健
(CBLL 無簡報檔)

CBLL 投資分析

看多重點:

  • 價值≥4
  • 股利≥2

分析結論

公司發布財報數據季度不足,尚無法提供評分

CBLL 近期報酬表現

-0.86%

Ceribell inc

1.99%

同產業平均

-0.64%

S&P500

與 CBLL 同產業的標的表現

  • QTRX Quanterix corp
    價值 4 分趨勢 2 分波段 4 分籌碼 3 分股利 1 分
    查看更多

CBLL 公司資訊

CeriBell, Inc. is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining highly portable and rapidly deployable hardware with artificial intelligence-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. The Ceribell System is FDA-cleared (510(k)) for indicating suspected seizure activity and utilized in intensive care units and emergency rooms across the United States. Clarity, its machine learning algorithm, continuously interprets a patient's EEG waveforms and displays actionable insights regarding seizure activity on the recorder. Its EEG portal is a cloud-based portal that enables real-time remote access to a patient's EEG data.

CBLL 股價